Diagnostic and therapeutic difficulties of pediatric encephalitis with a N Methyl D Aspartate in Libreville: about three cases.

Read full text
Authors: Angela Eurydias Pauline Mekame Meye, Midili Tecle Larissa, Léandre Mouelé Nguélé, Raïssa Koumba Maniaga, Simon Ategbo
Cited by: 0

Abstract

Anti-NMDAR antibody encephalitis is an autoimmune neurological disease, which is defined as an inflammation of the brain due to antibodies attached to N-Methyl-D-Aspartate receptors. This is the most common autoimmune encephalitis and a neurological emergency. It accounts for 4% of all encephalitis cases, making it the fifth most common cause after herpes simplex virus and varicella-zoster virus (VZV) infections. It is rare in pediatrics, with an incidence ranging from 0.07 to 0.085 per 100,000 children in Europe, but in Africa it remains underdiagnosed due to the very high cost of antibody testing in cerebrospinal fluid (CSF) and treatment. It is characterized by neuropsychiatric symptoms and leads to serious cognitive and psychomotor sequelae if left untreated. Therefore, we share our experience with three pediatric cases to clarify the circumstances of their onset, the various clinical signs, and finally, to highlight the diagnostic and management difficulties we encountered in our setting.

Fields of Study & Subjects

Autoimmune Neurological Disorders and Treatments Infectious Encephalopathies and Encephalitis Peripheral Neuropathies and Disorders

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
31 January 2026
Language
EN